1 | KDM1A, SFMBT1
|
| The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
|
| Tang M, Shen H, Jin Y, Lin T, Cai Q, Pinard MA, Biswas S, Tran Q, Li G, Shenoy AK, Tongdee E, Lin S, Gu Y, Law BK, Zhou L, McKenna R, Wu L, Lu J.
|
| J Biol Chem 288(38):27680-91. doi: 10.1074/jbc.M113.482349. Epub 2013 Aug 8.
2013
|
2 | KDM1A, RCOR1, SFMBT1
|
| SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors.
|
| Zhang J, Bonasio R, Strino F, Kluger Y, Holloway JK, Modzelewski AJ, Cohen PE, Reinberg D.
|
| Genes Dev 27(7):749-66. doi: 10.1101/gad.210963.112.
2013
|
3 | SFMBT1
|
| Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program.
|
| Lin S, Shen H, Li JL, Tang S, Gu Y, Chen Z, Hu C, Rice JC, Lu J, Wu L.
|
| J Biol Chem 288(9):6238-47. doi: 10.1074/jbc.M112.429605. Epub 2013 Jan 24.
2013
|
4 | SFMBT1
|
| Segmental copy number loss of SFMBT1 gene in elderly individuals with ventriculomegaly: a community-based study.
|
| Kato T, Sato H, Emi M, Seino T, Arawaka S, Iseki C, Takahashi Y, Wada M, Kawanami T.
|
| Intern Med 50(4):297-303. Epub 2011 Feb 15.
2011
|
5 | SFMBT1
|
| Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3.
|
| Wu S, Trievel RC, Rice JC.
|
| FEBS Lett 581(17):3289-96. Epub 2007 Jun 21. 2007
|
6 | L3MBTL1, L3MBTL2, MBTD1, SCMH1, SCML2, SFMBT1, SFMBT2
|
| Molecular characterization of h-l(3)mbt-like: a new member of the human mbt family.
|
| Wismar J.
|
| FEBS Lett 507(1):119-21. No abstract available. 2001
|
7 | SFMBT1
|
| Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.
|
| Morel S, Levy F, Burlet-Schiltz O, Brasseur F, Probst-Kepper M, Peitrequin AL, Monsarrat B, Van Velthoven R, Cerottini JC, Boon T, Gairin JE, Van den Eynde BJ.
|
| Immunity 12(1):107-17. 2000
|